Premium
Prophylactic granisetron for post‐spinal anesthesia shivering in cesarean section: A randomized controlled clinical study
Author(s) -
AbdelGhaffar Hala S.,
Moeen Seham M.
Publication year - 2019
Publication title -
acta anaesthesiologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.738
H-Index - 107
eISSN - 1399-6576
pISSN - 0001-5172
DOI - 10.1111/aas.13084
Subject(s) - medicine , shivering , granisetron , anesthesia , spinal anesthesia , randomized controlled trial , section (typography) , surgery , nausea , antiemetic , advertising , business
Background The serotonergic system is known to be involved in control of post‐anesthetic shivering. Our hypothesis was that prophylactic granisetrone (serotonin antagonist) might reduce incidence of post‐spinal anesthesia shivering in cesarean section. Methods Parturient scheduled for elective cesarean delivery under spinal anesthesia were allocated to receive 0.9% saline (Group I, n = 71), 1 mg granisetron (Group II, n = 69), or 0.7 mg granisetron (Group III, n = 72) before the spinal block. Assessment parameters included; hemodynamics, tympanic membrane temperature, neonatal Apgar score, shivering score, patient satisfaction scores about shivering prophylaxis and adverse effects. Results Clinically significant shivering was recorded in 55/71 patients (77.5%) in group I, 11/69 (15.9%) in group II and 21/72 (29.2%) in group III ( P = 0.000). The intensity of shivering was significantly lower in patients who received granisetron 1 mg compared with granisetron 0.7 mg or saline ( P = 0.000). Patients who received prophylactic granisetron 1 mg reported lower mean intraoperative arterial pressure and heart rate values and consumed higher doses of iv ephedrine compared with 0.7 mg granisetron or saline placebo ( P < 0.05). Pruritus significantly decreased from (22.5%) in control group to (0%) in granisetron groups ( P = 0.000). Nausea was reported in 8 vs 10 and four in group I, II and III, respectively ( P < 0.03). Sixteen vs eight and six patients vomited in group I, II, and III, respectively ( P < 0.03). Higher patient satisfaction scores were recorded in group II (9.83 ± 0.29, P < 0.03) and III (9.14 ± 1.04, P < 0.04), compared with control group (8.23 ± 1.14). Conclusion Prophylactic granisetron effectively reduced incidence and severity of perioperative shivering in a dose dependent manner, compared to placebo controls.